Lsh-deficient murine embryonal fibroblasts show reduced proliferation with signs of abnormal mitosis

Cancer Res. 2003 Aug 1;63(15):4677-83.

Abstract

Genomic hypomethylation and chromosomal instability are frequent characteristics of human cancer cells. Targeted deletion of Lsh leads to a global defect in genomic methylation, and Lsh-deficient mice die at birth with a reduced body weight. Here, we examine the growth pattern of embryonal fibroblasts derived from Lsh-/- mice. The absence of Lsh leads to a severe proliferative defect of fibroblasts with lower saturation density, early signs of senescence, and a lower frequency of immortalization. The impaired growth rate in vitro may be in part responsible for the small size of Lsh-deficient mice. In addition, Lsh-/- fibroblasts accumulated high centrosome numbers, formed multipolar spindles, displayed micronuclei formation, and elevated nuclear DNA content. A similar increase in centrosome abnormalities was observed when wild-type fibroblasts were treated with a DNA-demethylating agent, suggesting that genomic hypomethylation plays an important role in mitotic defects of Lsh-/- murine embryonal fibroblasts, possibly by altering chromatin structure. Because supernumerary centrosomes are a common feature in cancer cells, this Lsh-dependent pathway has the potential to contribute to genetic instability and chromosomal aberrations during tumor progression.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Azacitidine / analogs & derivatives*
  • Azacitidine / pharmacology
  • Cell Cycle / genetics
  • Cell Division / genetics
  • Cells, Cultured
  • Centrosome / drug effects
  • Centrosome / physiology
  • DNA Helicases / deficiency*
  • DNA Helicases / genetics
  • Decitabine
  • Embryo, Mammalian
  • Fibroblasts / cytology*
  • Fibroblasts / drug effects
  • Fibroblasts / enzymology*
  • Fibroblasts / physiology
  • Mice
  • Mitosis / genetics
  • Spindle Apparatus / metabolism

Substances

  • Decitabine
  • DNA Helicases
  • Azacitidine